Nalaganje...
Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer
The optimal neoadjuvant chemotherapy (NACT) regimen in triple-negative breast cancer (TNBC) has not been clearly defined. Achieving a pathologic complete response (pCR) provides important prognostic information, and, especially in TNBC, is considered a surrogate endpoint for event-free survival. Thu...
Shranjeno v:
| izdano v: | J Target Ther Cancer |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865448/ https://ncbi.nlm.nih.gov/pubmed/29577076 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|